BIRMINGHAM, UK — Modified-release (MR) metformin and an SGLT2 inhibitor (SGLT2i) should be the first line of treatment for most people with type 2 diabetes according to revised guidance from the ...
Metformin blunted exercise-induced improvements in vascular insulin sensitivity, aerobic fitness, inflammatory markers, and fasting glucose levels in adults at high risk for metabolic syndrome, ...
NEW YORK, Aug. 25 (UPI) --Medical science continues to develop new and innovative ways to boost health and well-being, but a relatively old drug -- metformin -- may hold the key to human longevity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results